Raymond James & Associates’s SI-BONE Inc SIBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-15,647
Closed -$492K 4242
2021
Q2
$492K Buy
15,647
+1,480
+10% +$47.9K ﹤0.01% 3089
2021
Q1
$451K Buy
14,167
+4,167
+42% +$128K ﹤0.01% 3099
2020
Q4
$299K Hold
10,000
﹤0.01% 3121
2020
Q3
$237K Buy
+10,000
New +$199K ﹤0.01% 3100

Other funds holding SIBN

Raymond James & Associates's SIBN Position: Q3 2021 in Review

Raymond James & Associates sold out of SI-BONE Inc (SIBN) in Q3 2021, closing a stake of 15,647 shares — an estimated $492K sold.

Raymond James & Associates first reported a position in SIBN in Q3 2020 and held it in 4 quarters. The position peaked at $492K in Q2 2021. 122 funds tracked by Wall St. Rank hold SIBN as of Q3 2021.

  • Raymond James & Associates reported no remaining SI-BONE Inc position as of Q3 2021 after selling out during the quarter.
  • Raymond James & Associates sold 15,647 SI-BONE Inc shares in Q3 2021, an estimated $492K.
  • Raymond James & Associates first reported a position in SI-BONE Inc in Q3 2020 and held it in 4 quarters.
  • Raymond James & Associates's SI-BONE Inc position peaked at $492K in Q2 2021.
  • 122 funds tracked by Wall St. Rank held SI-BONE Inc as of Q3 2021.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.